N-Tosyl-L-phenylalanyl chloromethyl ketone; Tos-Phe-CH2Cl; N-Tosyl-L-phenylalanine chloromethyl ketone; N-p-Tosyl-L-phenylalanine chloromethyl ketone; L-1-Tosylamido-2-phenylethyl chloromethyl ketone; l-N-(alpha-(Chloroacetyl)phenethyl)-p-toluenesulfonamide; (S)-N-(4-Chloro-3-oxo-1-phenylbutan-2-yl)-4-methylbenzenesulfonamide; Benzenesulfonamide,N-[(1S)-3-chloro-2-oxo-1-(phenylmethyl)propyl]-4-methyl-; CHEMBL60718; UNII-P598716LJT; MLS000028752; P598716LJT; N-[(2S)-4-chloro-3-oxo-1-phenylbutan-2-yl]-4-methylbenzenesulfonamide; SMR000058518; p-Toluenesulfonamide, N-(alpha-(chloroacetyl)phenethyl)-, (-)-; Benzenesulfonamide, N-(3-chloro-2-oxo-1-(phenylmethyl)propyl)-4-methyl-, (S)-; N-(p-Toluenesulfonyl)-L-phenylalanine chloromethyl ketone; L-1-4'-Tosylamino-2-phenylethyl chloromethyl ketone, 99+%; Benzenesulfonamide, N-[3-chloro-2-oxo-1-(phenylmethyl)propyl]-4-methyl-, (S)-; EINECS 206-954-6; Tosylphenylalanyl chloromethyl ketone, (L)-; BRN 2895215; L-Chloromethyl (2-phenyl-1-(p-toluenesulphonylamino)ethyl) ketone; Opera_ID_1094; Lopac-T-4376; Tosyl-Phe-CMK (TPCK); tosylphenylalanylchloromethane; Lopac0_001157; BSPBio_001541; KBioGR_000261; KBioSS_000261; L-1-p-Tosylamino-2-phenylethyl chloromethyl ketone; MLS001076075; MLS006010721; SCHEMBL927265; cid_439647; Tosyl-L-phenylalanylchloromethane; KBio2_000261; KBio2_002829; KBio2_005397; KBio3_000521; KBio3_000522; KS-00000XQS; BRD5988; DTXSID60883376; Benzenesulfonamide, N-((1S)-3-chloro-2-oxo-1-(phenylmethyl)propyl)-4-methyl-; Bio2_000261; Bio2_000741; HMS1361N03; HMS1791N03; HMS1989N03; HMS3263H15; HMS3402N03; ZINC901254; BRD-5988; Tox21_501157; 7793AH; BDBM50085363; MFCD00000935; NSC727365; PI-122; CCG-205231; LP01157; NSC-727365; SDCCGSBI-0051124.P003; IDI1_034011; NCGC00016020-01; NCGC00094419-01; NCGC00094419-02; NCGC00094419-03; NCGC00094419-04; NCGC00094419-05; NCGC00094419-06; NCGC00094419-07; NCGC00261842-01; AS-35326; p-Tosyl-L-phenylalanine chloromethylketone; EU-0101157; N-P-tosyl-L-phenylalanyl chloromethyl ketone; C02088; K-8605; L-1-Tosylamido-2-phenylethylchloromethyl ketone; T 4376; SR-01000076157; Q7827912; SR-01000076157-1; BRD-K07055988-001-02-4; L-1-TOSYLAMIDE-2-PHENYLETHYL-CHLOROMETHYL KETONE; l-N-(.alpha.-(Chloroacetyl)phenethyl)-p-toluenesulfonamide; (3S)-3-(p-Toluenesulfonyl)amino-1-chloro-4-phenyl-2-butanone; (S)-N-(4-Chloro-3-oxo-1-phenyl-2-butyl)-p-toluenesulfonamide; L-([Toluene-4-sulfonamido]-2-phenyl)ethyl chloromethyl ketone; p-Toluenesulfonamide, N-(.alpha.-(chloroacetyl)phenethyl)-, (-)-; N-[(1S)-1-benzyl-3-chloro-2-oxo-propyl]-4-methyl-benzenesulfonamide; N-p-Tosyl-L-phenylalanine chloromethyl ketone, >=97% (TLC), powder